Scholarlink

Purpose of Review <p>Polycystic ovary syndrome (PCOS) is a complex endocrine–metabolic disorder in which insulin resistance and chronic low-grade inflammation contribute to long-term cardiometabolic risk. Emerging evidence suggests that gut microbiota alterations and impaired intestinal barrier function may represent modifiable upstream drivers, particularly in specific patient subsets.</p> Recent Findings <p>PCOS has been associated with dysbiosis, increased intestinal permeability, and metabolic endotoxemia, a state of low-grade elevation of circulating lipopolysaccharide (LPS). LPS can activate Toll-like receptor 4 (TLR4) and downstream nuclear factor-κB (NF-κB) signaling, amplifying inflammatory tone and potentially worsening insulin signaling. Clinical studies increasingly report higher circulating markers of endotoxemia in PCOS and links with androgen excess and inflammatory markers, although causality remains unresolved. Conversely, skeletal muscle myokines induced by exercise show potential in counteracting these inflammatory signals. Interactions among diet (especially high saturated-fat meals), sleep disruption, psychosocial stress, and physical inactivity may further shape barrier integrity and postprandial endotoxemia.</p> Summary <p>A gut-barrier–endotoxemia framework offers a metabolically coherent explanation for heterogeneity in PCOS, particularly in phenotypes with obesity and insulin resistance. However, biomarker standardization and well-designed interventions are required to determine which patients derive the greatest benefit from endotoxemia-targeted lifestyle or adjunctive therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Skeletal Muscle as an Endocrine Firewall: Mitigating Metabolic Endotoxemia and Insulin Resistance in Polycystic Ovary Syndrome

  • 期刊论文

  • 发表日期：

    2026年3月14日

查看全文
  • Qianqian Li,
  • Yini Wu,
  • Leqin Chen,
  • Ronghui Wang

摘要

Purpose of Review

Polycystic ovary syndrome (PCOS) is a complex endocrine–metabolic disorder in which insulin resistance and chronic low-grade inflammation contribute to long-term cardiometabolic risk. Emerging evidence suggests that gut microbiota alterations and impaired intestinal barrier function may represent modifiable upstream drivers, particularly in specific patient subsets.

Recent Findings

PCOS has been associated with dysbiosis, increased intestinal permeability, and metabolic endotoxemia, a state of low-grade elevation of circulating lipopolysaccharide (LPS). LPS can activate Toll-like receptor 4 (TLR4) and downstream nuclear factor-κB (NF-κB) signaling, amplifying inflammatory tone and potentially worsening insulin signaling. Clinical studies increasingly report higher circulating markers of endotoxemia in PCOS and links with androgen excess and inflammatory markers, although causality remains unresolved. Conversely, skeletal muscle myokines induced by exercise show potential in counteracting these inflammatory signals. Interactions among diet (especially high saturated-fat meals), sleep disruption, psychosocial stress, and physical inactivity may further shape barrier integrity and postprandial endotoxemia.

Summary

A gut-barrier–endotoxemia framework offers a metabolically coherent explanation for heterogeneity in PCOS, particularly in phenotypes with obesity and insulin resistance. However, biomarker standardization and well-designed interventions are required to determine which patients derive the greatest benefit from endotoxemia-targeted lifestyle or adjunctive therapies.